ADC Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	81.36	70.84	69.56	209.91	33.92
Revenue Growth (YoY)	14.85%	1.84%	-66.86%	518.89%	-
Cost of Revenue	5.8	5.95	2.53	3.3	1.39
Gross Profit	75.56	64.89	67.03	206.61	32.52
Selling, General & Admin	79.93	85.91	105.89	143.49	136.24
Research & Development	104.01	109.63	127.13	186.46	158
Other Operating Expenses	13.12	-	-	-	-
Total Operating Expenses	197.06	195.54	233.02	329.95	294.24
Operating Income	-121.5	-130.65	-165.99	-123.34	-261.72
Interest Income	8.81	12.27	10.54	2.57	0.07
Interest Expense	-51.63	-50.21	-46.33	-36.73	-18.34
Other Non-Operating Income (Expense)	22.71	12.46	6.35	10.69	28.49
Total Non-Operating Income (Expense)	-20.11	-25.48	-29.43	-23.47	10.22
Pretax Income	-141.61	-156.14	-195.42	-146.82	-251.51
Provision for Income Taxes	1.02	0.17	39.11	0.23	-
Net Income	-142.62	-157.85	-240.05	-157.13	-230.03
Minority Interest in Earnings	-	1.54	5.53	10.08	-
Net Income to Common	-142.62	-157.85	-240.05	-157.13	-230.03
Shares Outstanding (Basic)	127	97	82	78	77
Shares Outstanding (Diluted)	127	97	82	78	77
Shares Change (YoY)	30.78%	18.91%	4.55%	1.83%	17.33%
EPS (Basic)	-1.12	-1.62	-2.94	-2.01	-3.00
EPS (Diluted)	-1.12	-1.62	-2.94	-2.01	-3.00
Shares Outstanding	125.75	98.86	82.29	80.64	76.81
Free Cash Flow	-141.44	-124.7	-121.9	-139	-236.81
Free Cash Flow Per Share	-1.11	-1.28	-1.49	-1.78	-3.09
Gross Margin	92.87%	91.60%	96.36%	98.43%	95.89%
Operating Margin	-149.34%	-184.44%	-238.63%	-58.76%	-771.65%
Profit Margin	-175.31%	-220.65%	-337.16%	-70.05%	-741.53%
FCF Margin	-173.85%	-176.04%	-175.25%	-66.22%	-698.20%
EBITDA	-119.62	-127.38	-162.72	-120.96	-259.09
EBITDA Margin	-147.03%	-179.82%	-233.93%	-57.62%	-763.89%
EBIT	-121.5	-130.65	-165.99	-123.34	-261.72
EBIT Margin	-149.34%	-184.44%	-238.63%	-58.76%	-771.65%
Effective Tax Rate	-0.72%	-0.11%	-20.01%	-0.15%	0.00%

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q